Insider Transactions in Q2 2023 at Ge Health Care Technologies Inc. (GEHC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
1,218,685
-1.94%
|
-
|
|
Jun 14
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
2,531,315
-3.87%
|
-
|
|
Jun 12
2023
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
25,000,000
-27.68%
|
-
|
|
Jun 08
2023
|
Roland Rott CEO, Imaging |
SELL
Open market or private sale
|
Direct |
2,473
-9.97%
|
$190,421
$77.37 P/Share
|
|
Jun 01
2023
|
James Saccaro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,693
+25.46%
|
-
|
|
May 23
2023
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
H Lawrence Culp Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+0.61%
|
-
|
|
May 23
2023
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,798
+35.1%
|
-
|
|
May 23
2023
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,992
+36.0%
|
-
|
|
May 23
2023
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+50.0%
|
-
|
|
May 23
2023
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,584
+43.66%
|
-
|
|
May 23
2023
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,798
+35.1%
|
-
|
|
Apr 01
2023
|
Helmut Zodl Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,448
-6.11%
|
$282,736
$82.12 P/Share
|
|
Apr 01
2023
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.26%
|
$68,634
$82.12 P/Share
|